Liposomal iron is a pharmaceutical formulation of iron enclosed in liposomes, which are spherical lipid bilayer vesicles. This technology is used to improve the bioavailability of iron, an essential mineral that is often poorly absorbed by the body. The liposomal encapsulation allows for targeted delivery and protection of the iron from degradation and oxidation. Synonyms for liposomal iron include iron liposomes, liposomal iron complex, and iron encapsulated in liposomes.
The iron particles can be in the form of iron salts, such as ferrous sulfate or ferrous gluconate. The lipids used to form the bilayer can vary, but commonly used lipids include phosphatidylcholine and cholesterol.
Characteristics of liposomal iron include improved absorption and decreased gastrointestinal side effects compared to traditional iron supplements. Liposomal iron has also shown potential for use in treating iron deficiency anemia, a common condition characterized by low levels of iron in the blood. However, as with any medication, liposomal iron should be used only under the guidance of a healthcare professional. Liposomal iron has been explored for various applications in the pharmaceutical industry, particularly for the treatment of iron deficiency anemia. WBCIL or West Bengal Chemical Industries Limited is one of the leading Liposomal iron exporters in India.
Molecular Formula –
Molecular Weight –
CAS No –
Shelf Life –
HSN Code –
Packing Size –
Storage Condition –
Additional Info –
Iron supplementation: Liposomal iron has been shown to be an effective way to supplement iron in individuals with iron deficiency anemia. The liposomal formulation improves the bioavailability of iron and reduces the side effects associated with traditional iron supplements, such as constipation and gastrointestinal irritation.
Cancer therapy: Liposomal iron has also been investigated as a potential therapeutic agent for cancer. Iron is essential for cancer cell growth and proliferation, and liposomal iron can be targeted specifically to cancer cells, leading to increased iron uptake and potentially inhibiting cancer growth.
Imaging: Liposomal iron nanoparticles can also be used as contrast agents for magnetic resonance imaging (MRI). These nanoparticles can be designed to accumulate in specific tissues or cells, allowing for more precise imaging of diseases such as cancer and inflammation.
Drug delivery: Liposomal iron nanoparticles can also be used as carriers for drug delivery. By encapsulating drugs within the liposomes, they can be targeted to specific cells or tissues, improving drug efficacy and reducing side effects.